STEPHANIE PILKINGTON: Open Payments
NPI 1376795914 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 57 payments from 13 companies in 2025. Trend: 2023 $1,625 · 2024 $1,271 · 2025 $1,530
Food & beverage: $1,530
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $279 |
| Abbott Laboratories | 3 | $272 |
| Merck Sharp & Dohme LLC | 8 | $198 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $164 |
| Daiichi Sankyo Inc. | 3 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| PFIZER INC. | 5 | $83 |
| Novo Nordisk Inc | 3 | $80 |
| Alnylam Pharmaceuticals Inc. | 4 | $58 |
| Amgen Inc. | 3 | $54 |
Products named: LEQVIO, AVEIR, Kerendia, VERQUVO, INJECTAFER, CAMZYOS, Wegovy, AMVUTTRA.
Industry payments across CA — which companies pay providers there.
